Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Raul Córdoba
Observed name:
Raul Cordoba
Institutions:
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Universidad Autónoma de Madrid
Observed institutions:
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Universidad Autónoma de Madrid
ORCID:
0000-0002-7654-8836
Observed ORCID:
0000-0002-7654-8836
OpenAlex ID:
A5127864521
A challenging case of cutaneous follicular lymphoma: molecular features do not always predict clinical behaviour
2026
·
Francisco Javier Díaz de la Pinta
, Marie-Laure García
, et al.
·
Pathology
Supplementary Materials S1 from Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non–Hodgkin Lymphoma (CAPITAL)
2026
·
Daniel J. Hodson
, Geoffrey Shouse
, et al.
Supplementary Table S1 from Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non–Hodgkin Lymphoma (CAPITAL)
2026
·
Daniel J. Hodson
, Geoffrey Shouse
, et al.
Data from Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non–Hodgkin Lymphoma (CAPITAL)
2026
·
Daniel J. Hodson
, Geoffrey Shouse
, et al.
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type